🕵️ OVID Therapeutics Inc. ($OVID)
SEC insider & ownership activity, last 12 months · CIK 1636651 · every row links its SEC filing
Over the last 12 months insiders sold $29K with no open-market buying against it. Margaret A. Alexander sold $17K in discretionary trades (Feb). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $29K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Margaret A. Alexander | 0 | – | 1 | $17K | Feb 23, 2026 |
| Jeffrey A. Rona | 0 | – | 1 | $12K | Feb 23, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Takeda Pharmaceutical Company Limited | 12.3% | 13G | Dec 9, 2025 | filing ↗ | |
| Janus Henderson Group PLC | 10.0% | 13G | Dec 8, 2025 | filing ↗ | |
| RA Capital Management, L.P. | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Peter Kolchinsky | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Rajeev Shah | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| RA Capital Healthcare Fund, L.P. | 9.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Sirenia Capital Management LP | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Alex Silverstein | 9.9% | 13G | May 15, 2026 | filing ↗ | |
| Takeda Pharmaceutical U.S.A., Inc. | 9.8% | 13G | Dec 9, 2025 | filing ↗ | |
| Affinity Healthcare Fund, LP | 9.0% | 13G | Dec 18, 2025 | filing ↗ | |
| Affinity Asset Advisors, LLC | 7.9% | 13G | Aug 13, 2026 | filing ↗ | |
| Michael Cho | 7.9% | 13G | Aug 13, 2026 | filing ↗ | |
| Eventide Asset Management, LLC | 6.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Finny Kuruvilla, M.D., PH. D. | 6.3% | 13G | Aug 14, 2026 | filing ↗ | |
| Robin C. John | 6.3% | 13G | Aug 14, 2026 | filing ↗ | |
| BlackRock, Inc. | 5.8% | 13G | Jul 29, 2026 | filing ↗ | |
| Balyasny Asset Management L.P. | 5.3% | 13G | May 15, 2026 | filing ↗ | |
| ADAR1 Capital Management, LLC | 5.1% | 13G | Aug 14, 2026 | filing ↗ | |
| Daniel Schneeberger | 5.1% | 13G | Aug 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Jeffrey A. Rona | $910K | Aug 24, 2026 | filing ↗ |
| Jeffrey A. Rona | $420K | Aug 14, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Financial Statements and Exhibits (9.01) | Aug 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 5, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Other events (8.01) | Apr 17, 2026 | filing ↗ |
| Material agreement (1.01) | Mar 17, 2026 | filing ↗ |
| Earnings (2.02) | Mar 17, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 17, 2026 | filing ↗ |
| Other events (8.01) | Dec 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 18, 2025 | filing ↗ |
| Shareholder vote (5.07) | Dec 11, 2025 | filing ↗ |
| Earnings (2.02) | Nov 12, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 2, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 2, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Oct 2, 2025 | filing ↗ |
| Other events (8.01) | Oct 2, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 2, 2025 | filing ↗ |